NEW YORK (Reuters) - Purdue Pharma is close to a new bankruptcy settlement with its owners, members of the wealthy Sackler ...
The deal reached Thursday would require members of the Sackler family who own the drugmaker to pay as much as $6 billion in cash. That's at least $1 billion more than previously agreed on.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback